Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EU Notified Bodies Vigilant In Checking Technical Files - British Survey

This article was originally published in The Gray Sheet

Executive Summary

A survey of six European Union notified bodies (NBs) located in the UK (four), Germany (one) and Ireland (one) showed that "nearly 100%" inspected the technical files for CE-marked products during initial device manufacturer audits, John Worroll, section head, regulatory affairs and European business, UK Medical Devices Agency (MDA), said.

You may also be interested in...

MDA To Increase Audits Of Notified Bodies, Manufacturers During 1999-2000

The UK's Medical Devices Agency (MDA) intends to audit the performance of active notified bodies in Britain "at least once a year" and take "any action necessary" to maintain standards of performance "at the required level," the agency states in its recently released "Business Plan 1999-2000."

Cosmetic And Personal Care Trademark Review 24 November, 2020

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts